Khiron Life Sciences Corp.
Rank 65
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$0.6797
USD
7.06%
Market cap
$77,433,984
Total volume
$486,556
Shares outstanding
113,927,120
Rank 65
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$249,750
|
51.33% |
$0.6797
|
| KHRNF |
Total volume
$236,806
|
48.67% |
Stock price
$0.9400
|
Chart